Stay updated on Venetoclax in Myeloma with Bortezomib: Clinical Trial

Sign up to get notified when there's something new on the Venetoclax in Myeloma with Bortezomib: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Venetoclax in Myeloma with Bortezomib: Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The site revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-10-29T22:18:37.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A site-wide notice was added about NIH websites transitioning terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    0.5%
    Check dated 2026-10-22T22:58:31.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov site revision changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-15T22:23:33.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The site footer now identifies the ClinicalTrials.gov release as v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-08T22:16:35.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    A new revision entry (v3.7.0) has been added to the study history and the previous revision (v3.6.6) has been removed, updating the record's version history.
    Difference
    0.1%
    Check dated 2026-09-17T20:48:03.000Z thumbnail image
  8. Check
    115 days ago
    Change Detected
    Summary
    A new site revision tag 'Revision: v3.6.4' was added, replacing 'Revision: v3.6.3', indicating a minor system update to the page rendering.
    Difference
    0.1%
    Check dated 2026-07-23T09:42:17.000Z thumbnail image

Stay in the know with updates to Venetoclax in Myeloma with Bortezomib: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Venetoclax in Myeloma with Bortezomib: Clinical Trial page.